Literature DB >> 21109976

Cancer cachexia: physical activity and muscle force in tumour-bearing rats.

Míriam Toledo1, Sílvia Busquets, Sònia Sirisi, Roberto Serpe, Marcel Orpí, Joana Coutinho, Raquel Martínez, Francisco J López-Soriano, Josep M Argilés.   

Abstract

Rats bearing the Yoshida AH-130 ascites hepatoma are subjected to substantial weight loss, which is accompanied by anorexia at the end of the tumour cycle. Total physical activity (measured using the IR Actimeter system and Actitrack software) was determined during 11 days in control and tumour-bearing animals, skeletal muscle strength being also by the grip-strength test. The results presented clearly show that the presence of the tumour induces an earlier decrease in physical performance, which affects both skeletal muscle force and physical activity (both locomotor movements and stereotyped movements and distance travelled, among others parameters).

Entities:  

Mesh:

Year:  2011        PMID: 21109976

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

Review 1.  Cancer cachexia, mechanism and treatment.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Hisahiro Matsubara; Kazuaki Takabe
Journal:  World J Gastrointest Oncol       Date:  2015-04-15

2.  Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity.

Authors:  Sílvia Busquets; Míriam Toledo; Sònia Sirisi; Marcel Orpí; Roberto Serpe; Joana Coutinho; Raquel Martínez; Josep M Argilés; Francisco J López-Soriano
Journal:  Exp Ther Med       Date:  2011-04-28       Impact factor: 2.447

Review 3.  Exercise as a therapy for cancer-induced muscle wasting.

Authors:  Jessica L Halle; Brittany R Counts; James A Carson
Journal:  Sports Med Health Sci       Date:  2020-12-03

4.  Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function.

Authors:  Diana M Norden; Sabahattin Bicer; Yvonne Clark; Runfeng Jing; Christopher J Henry; Loren E Wold; Peter J Reiser; Jonathan P Godbout; Donna O McCarthy
Journal:  Brain Behav Immun       Date:  2014-08-04       Impact factor: 7.217

5.  Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance.

Authors:  Sílvia Busquets; Míriam Toledo; Marcel Orpí; David Massa; Maria Porta; Eva Capdevila; Núria Padilla; Valentina Frailis; Francisco J López-Soriano; H Q Han; Josep M Argilés
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-11-08       Impact factor: 12.910

6.  Motor protein function in skeletal abdominal muscle of cachectic cancer patients.

Authors:  Sultan Taskin; Vera Isabell Stumpf; Jeannine Bachmann; Cornelia Weber; Marc Eric Martignoni; Oliver Friedrich
Journal:  J Cell Mol Med       Date:  2013-11-19       Impact factor: 5.310

7.  Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats.

Authors:  Anna Salazar-Degracia; Sílvia Busquets; Josep M Argilés; Francisco J López-Soriano; Esther Barreiro
Journal:  PeerJ       Date:  2017-12-13       Impact factor: 2.984

8.  Are there any benefits of exercise training in cancer cachexia?

Authors:  Josep M Argilés; Sílvia Busquets; Francisco J López-Soriano; Paola Costelli; Fabio Penna
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-05-08       Impact factor: 12.910

Review 9.  Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases.

Authors:  David Maughan; Michael Toth
Journal:  Biology (Basel)       Date:  2014-09-22

10.  A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy.

Authors:  Míriam Toledo; Fabio Penna; Francesc Oliva; Melania Luque; Angelica Betancourt; Enrica Marmonti; Francisco J López-Soriano; Josep M Argilés; Sílvia Busquets
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-05-14       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.